Abstract:In February 2016, the World Health Organization declared a Public Health Emergency of International Concern on Zika Virus (ZIKV), because of its association with severe fetal anomalies of congenitally infected humans. This has led to urgent efforts by academic, federal, and industry research groups to improve our understanding of the pathogenesis of ZIKV and to develop detection methods, therapeutic strategies, and vaccines. Although we still do not have the entire picture of the pathogenesis of ZIKV, extensive research has been conducted on related pathogenic flaviviruses (i.e., dengue virus, West Nile virus, and yellow fever virus). Binding to glycosaminoglycans (GAGs) through its envelope protein is the first step in successful host cell invasion of dengue virus. In this study, we examined ZIKV envelope protein (ZIKV E) binding to GAGs in a real time interaction study using surface plasmon resonance (SPR) to explore the role of GAGs in host cell entry of ZIKV into placenta and brain. ZIKV E strongly binds (KD = 443 nM) pharmaceutical heparin (HP), a highly sulfated GAG, and binds with lower avidity to less sulfated GAGs, suggesting that the ZIKV E-GAG interaction may be electrostatically driven. Using SPR competition assays with various chain length HP oligosaccharides (from 4 to 18 saccharide units in length), we observed that ZIKV E preferentially binds to longer HP oligosaccharides (with 8-18 saccharides). Next, we examined GAGs prepared from human placentas to determine if they bound ZIKV E, possibly mediating placental cell invasion of ZIKV. Compositional analysis of these GAGs as well as SPR binding studies showed that both chondroitin sulfate and heparan sulfate GAGs, present on the placenta, showed low-micromolar interactions with ZIKV E. Both porcine brain CS and HS also showed micromolar binding with ZIKV E. Moreover, heparan sulfate with a higher TriS content, the dominant repeating unit of HP, shows a high affinity for ZIKV E. These results suggest that GAGs may be utilized as attachment factors for host cell entry of Zika virus as they do in other pathogenic flaviviruses. They may also assist us in advancing our understanding of the pathogenesis of ZIKV and guide us in designing therapeutics to combat ZIKV with more insight.

Pathogenesis and Inhibition of Flaviviruses from a Carbohydrate Perspective

Glycosylation of viral proteins: Implication in virus–host interaction and virulence

Flavivirus Envelope Protein Glycosylation: Impacts on Viral Infection and Pathogenesis

Viral receptors for flaviviruses: Not only gatekeepers

The Role of Noncoding RNA in the Transmission and Pathogenicity of Flaviviruses

The Effect and Function of Glycosylation for Influenza Virus

Exploitation of glycosylation in enveloped virus pathobiology

A Review on The Pathogenesis of Cardiovascular Disease of Flaviviridea Viruses Infection

New Progress of Glycan As Receptors for Influenza Virus

Innate Immune Evasion Mediated By Flaviviridae Non-Structural Proteins

The Mechanism of Glycosylation in SARS-CoV-2 Infection and Application in Drug Development

Glycan Nanostructures of Human Coronaviruses

The interactions of flaviviruses with cellular receptors: Implications for virus entry

Their Roles in Viral Transmission, Immune Evasion, and Inflammation

Flaviviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines

Immune Evasion Strategies of Flaviviruses

Interaction of Zika Virus Envelope Protein with Glycosaminoglycans

Structures And Functions Of The Envelope Glycoprotein In Flavivirus Infections

Mosquito-Borne Flaviviruses and Current Therapeutic Advances

Molecular biology of flaviviruses